Credit: Getty

When SARS-CoV-2 started spreading, the countries of the world had no pandemic vaccine plans in place. But a lot can happen in six months.

Today, there are 40 vaccine candidates for the coronavirus being studied in humans — including nine in the final phase of testing.

There’s also the world’s first attempt at a global effort to ensure that, when we have a working vaccine or vaccines, all countries have access, no matter their GDP.

The initiative is called Covax, and it aims to support the development and equitable distribution of 2 billion doses of Covid-19 vaccines before the end of 2021. It’s the biggest multilateral effort since the Paris climate agreement, according to Seth Berkley, the CEO of Gavi, the Vaccine Alliance, one of the partners behind Covax, along with the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI).

It’s the “busiest period of my life,” he told Vox recently.

Seth Berkley, CEO of Gavi, the Vaccine Alliance.

As of October 9, 171 high-, low-, and middle-income countries — representing […]

Read the Full Article